These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32836216)

  • 1. Controlled attenuation parameter value-based diagnostic algorithm improves the accuracy of liver stiffness measurement in chronic hepatitis B patients.
    Fan Y; Wang L; Ding Y; Sheng Q; Zhang C; Li Y; Han C; Dou X
    Aging (Albany NY); 2020 Aug; 12(16):16072-16082. PubMed ID: 32836216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moderate to severe hepatic steatosis leads to overestimation of liver stiffness measurement in chronic hepatitis B patients without significant fibrosis.
    Shen F; Mi YQ; Xu L; Liu YG; Wang XY; Pan Q; Zhang RN; Hu XQ; Xu LM; Fan JG
    Aliment Pharmacol Ther; 2019 Jul; 50(1):93-102. PubMed ID: 31094016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How intrahepatic cholestasis affects liver stiffness in patients with chronic hepatitis B: a study of 1197 patients with liver biopsy.
    Guo H; Liao M; Jin J; Zeng J; Li S; Schroeder DR; Zheng J; Zheng R; Chen S
    Eur Radiol; 2020 Feb; 30(2):1096-1104. PubMed ID: 31673836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic steatosis leads to overestimation of liver stiffness measurement in both chronic hepatitis B and metabolic-associated fatty liver disease patients.
    Liu J; Ma Y; Han P; Wang J; Liu YG; Shi RF; Li J
    Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):101957. PubMed ID: 35609821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A diagnostic algorithm for assessment of liver fibrosis by liver stiffness measurement in patients with chronic hepatitis B.
    Cai YJ; Dong JJ; Wang XD; Huang SS; Chen RC; Chen Y; Wang YQ; Song M; Chen YP; Li Z; Zhou MT; Shi KQ
    J Viral Hepat; 2017 Nov; 24(11):1005-1015. PubMed ID: 28419755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B.
    Cardoso AC; Beaugrand M; de Ledinghen V; Douvin C; Poupon R; Trinchet JC; Ziol M; Bedossa P; Marcellin P
    Ann Hepatol; 2015; 14(6):826-36. PubMed ID: 26436354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
    Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of controlled attenuation parameter for liver steatosis in patients with chronic hepatitis B.
    Wang CY; Lu W; Hu DS; Wang GD; Cheng XJ
    World J Gastroenterol; 2014 Aug; 20(30):10585-90. PubMed ID: 25132779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A noninvasive indicator for the diagnosis of early hepatitis B virus-related liver fibrosis.
    Li B; Zhang L; Zhang Z; Yan G; Zhu L; Lu W; Yu H
    Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):218-223. PubMed ID: 30277926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B.
    Goyal R; Mallick SR; Mahanta M; Kedia S; Shalimar ; Dhingra R; Sharma H; Das P; Datta Gupta S; Panda S; Acharya SK
    J Gastroenterol Hepatol; 2013 Nov; 28(11):1738-45. PubMed ID: 23808910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B?
    Kim SU; Kim DY; Park JY; Lee JH; Ahn SH; Kim JK; Paik YH; Lee KS; Chon CY; Choi EH; Song KJ; Park YN; Han KH
    J Clin Gastroenterol; 2010 Jan; 44(1):66-71. PubMed ID: 19609218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B.
    Chan HL; Wong GL; Choi PC; Chan AW; Chim AM; Yiu KK; Chan FK; Sung JJ; Wong VW
    J Viral Hepat; 2009 Jan; 16(1):36-44. PubMed ID: 18673426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis.
    Lee JI; Lee HW; Lee KS
    World J Gastroenterol; 2019 Sep; 25(33):4959-4969. PubMed ID: 31543686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel liver stiffness measurement-based prediction model for cirrhosis in hepatitis B patients.
    Kim BK; Han KH; Park JY; Ahn SH; Chon CY; Kim JK; Paik YH; Lee KS; Park YN; Kim DY
    Liver Int; 2010 Aug; 30(7):1073-81. PubMed ID: 20492510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
    Myers RP; Pollett A; Kirsch R; Pomier-Layrargues G; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    Liver Int; 2012 Jul; 32(6):902-10. PubMed ID: 22435761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of Controlled Attenuation Parameter and Liver Stiffness Measurement for the Identification of Extended-criteria Donors and Risk-assessment in Liver Transplantation.
    Duarte-Rojo A; Heimbach JK; Borja-Cacho D; Barone GW; Shaheen MF; Lamps LW; Graham RP; Tan EK; Concepcion W; Kim WR
    Transplantation; 2022 Feb; 106(2):318-327. PubMed ID: 33675319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B.
    Wong GL; Chan HL; Choi PC; Chan AW; Yu Z; Lai JW; Chan HY; Wong VW
    Aliment Pharmacol Ther; 2014 Jan; 39(2):197-208. PubMed ID: 24261924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probability-based interpretation of liver stiffness measurement in untreated chronic hepatitis B patients.
    Wong VW; Lampertico P; de Lédinghen V; Chang PE; Kim SU; Chen Y; Chan HL; Mangia G; Foucher J; Chow WC; Ahn SH; Hou J
    Dig Dis Sci; 2015 May; 60(5):1448-56. PubMed ID: 25563720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.
    Tan YW; Zhou XB; Ye Y; He C; Ge GH
    World J Gastroenterol; 2017 Aug; 23(31):5746-5754. PubMed ID: 28883700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria.
    Zhou H; Long J; Hu H; Tian CY; Lin SD
    World J Gastroenterol; 2019 Sep; 25(35):5323-5333. PubMed ID: 31558876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.